Boehringer Ingelheim, a German drugmaker, expressed its aspiration to launch survodutide, a drug candidate co-developed with Zealand Pharma (ZELA.CO), with the potential to treat obesity and…
Browsing: #BOEHRINGER
Germany’s leading pharmaceutical company Boehringer Ingelheim released a statement stating it would conduct three late-stage studies for its obesity drug candidate this Thursday after a result…